Back to top

AVEO Pharmaceuticals (AVEO) Soars: Stock Adds 6.4% in Session

Read MoreHide Full Article

AVEO Pharmaceuticals, Inc. (AVEO - Free Report) was a big mover last session, as the company saw its shares rise more than 6% on the day. The move came on solid volume too with far more shares changing hands than in a normal session. This continues the recent uptrend for the company as the stock is now up 25.5% in the past one-month time frame.

The company has seen no estimate revisions over the past few weeks and the Zacks Consensus Estimate for the current quarter remained unchanged. The recent price action is encouraging though, so make sure to keep a close watch on this firm in the near future.

AVEO Pharmaceuticals currently has a Zacks Rank #3 (Hold) while its Earnings ESP is 0.00%.  

A better-ranked stock in the Medical - Biomedical and Genetics industry is Anika Therapeutics Inc. (ANIK - Free Report) , which currently carries a Zacks Rank #1 (Strong Buy). You can see the complete list of today’s Zacks #1 Rank stocks here.

Is AVEO going up? Or down? Predict to see what others think: Up or Down

5 Medical Stocks to Buy Now

Zacks names 5 companies poised to ride a medical breakthrough that is targeting cures for leukemia, AIDS, muscular dystrophy, hemophilia, and other conditions.

New products in this field are already generating substantial revenue and even more wondrous treatments are in the pipeline. Early investors could realize exceptional profits.

Click here to see the 5 stocks >>




In-Depth Zacks Research for the Tickers Above


Normally $25 each - click below to receive one report FREE:


Anika Therapeutics Inc. (ANIK) - free report >>

AVEO Pharmaceuticals, Inc. (AVEO) - free report >>

More from Zacks Tale of the Tape

You May Like